Elanco Animal Health (ELAN) is positioned to potentially beat earnings estimates in its upcoming November 6, 2026 report. The company has a strong track record of beating estimates with an average surprise of 21.79% over the past two quarters. With a positive Earnings ESP of +3.70% and a Zacks Rank #2 (Buy), analysts predict a 70% probability of another earnings beat.
ELAN
Elanco Animal Health Incorporated · NYSE
Sign up free to see this.
Mkt Cap
$11.4B
Volume
3.6M
52W High
$27.98
52W Low
$19.40
PE Ratio
—
Avg Vol
5.4M
As of 10/26/26
Div Yield
—
Beta
1.30
As of 10/26/26
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about ELAN?
Latest news
News ›Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.